Biomarin Pharmaceutical Inc (NASDAQ:BMRN)

Delayed Data
As of Aug 12
 -0.01 / -0.01%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Biomarin Pharmaceutical Inc have a median target of 114.50, with a high estimate of 174.00 and a low estimate of 70.00. The median estimate represents a +20.45% increase from the last price of 95.06.

Analyst Recommendations

The current consensus among 23 polled investment analysts is to Buy stock in Biomarin Pharmaceutical Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -97.69%
Growthannually 303.09%


Growthquarterly -2.72%
Growthannually 15.07%
Key to the earnings and sales forecast charts.